Published in collaboration with Deloitte Consulting LLP, The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation...
NON - MEMBER PRICE: $0.00 | MEMBER PRICE: $0.00
The 89th Edition HDA Factbook (2017-2018) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.
NON - MEMBER PRICE: $0.00 | MEMBER PRICE: $0.00
This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.
NON - MEMBER PRICE: $0.00 | MEMBER PRICE: $0.00
(Webinar Held: December 10, 2018) HDA wants to keep you informed of the many benefits of membership to you and your company. In this webinar, learn about the full scope of your HDA member benefits, and...
Developed by HDMA’s Returns Task Force, these voluntary guidelines provide insights into industry recall and withdrawal practices, as well as strategies for manufacturers and distributors to effectively...
PRICE : $0.00 - $495.00
Add to Cart
Trading partners may use this sample returned goods debit memo template to clearly convey the pertinent information about returned pharmaceuticals and facilitate the credit reconciliation process.
PRICE : $0.00 - $0.00
Add to Cart
This report focuses on the opportunities to improve communications between trading partners as a branded pharmaceutical product nears the end of its patent protection to better manage inventory and reduce...
PRICE : $0.00 - $0.00
Add to Cart
Developed by HDMA’s Returns Task Force, this report addresses key issues and recommends process improvements for returned or unsalable healthcare products.
PRICE : $0.00 - $495.00
Add to Cart
Developed for HDMA’s Returns Task Force (RTF) by Raftery Resource Network, this report describes the major causes of unsalable pharmaceutical returns and actions an individual company may take to address...
PRICE : $0.00 - $495.00
Add to Cart
These recommendations suggest practices that a pharmaceutical entity could employ to identify and help minimize the risks associated with storing pharmaceutical products.
PRICE : $0.00 - $495.00
Add to Cart
Violent attacks are increasing in the last mile for pharmaceutical supply chain distribution. These suggested guidelines offer companies seeking to strengthen their in-transit security program a directed...
PRICE : $0.00 - $495.00
Add to Cart
Developed by HDMA’s Logistics Operations Committee, these guidelines outline steps pharmaceutical supply chain stakeholders can take to protect products while in transit.
PRICE : $0.00 - $495.00
Add to Cart
This white paper, produced by Hamacher Resource Group in partnership with HDMA and the Consumer Healthcare Products Association, is a follow-up to the 2011 white paper, “Supply Chain Collaboration: Maximizing...
PRICE : $0.00 - $0.00
Add to Cart
Produced by HDMA in cooperation with Hamacher Research Group, this white paper identifies and explores the challenges and changes ahead that will test the industry, as pharmacies face new competitive pressures...
PRICE : $0.00 - $0.00
Add to Cart